Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1UB-312----1件: 6 💬
2UB-312 injection----2件: 6, 17 💬
3Ubenimex1件: Ubenimex1件: Ubenimex 💬 1件: ANPEP 💬 3件: Glutathione metabolism, Hematopoietic cell lineage, Renin-angiotensin system 💬1件: 86 💬
4Ubidecarenon----1件: 5 💬
5Ubiquinol1件: Ubiquinol---3件: 6, 8, 17 💬
6Ublituximab1件: Ublituximab1件: Ublituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
7Ubltuximab----1件: 13 💬
8Ubrogepant1件: Ubrogepant1件: Ubrogepant 💬 1件: CALCRL 💬 2件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction 💬1件: 226 💬
9UC-MSC+dmards----1件: 46 💬
10UC-mscs1件: Human Umbilical Cord Mesenchymal Stem Cells---1件: 46 💬
11UC-mscs BY peripheral intravenous infusion1件: Human Umbilical Cord Mesenchymal Stem Cells---1件: 96 💬
12Ucar T-cell----3件: 11, 13, 51 💬
13Ucar T-cell group----3件: 11, 49, 61 💬
14UCB 34714----1件: 309 💬
15UCB L059----1件: 13 💬
16UCB0022----1件: 6 💬
17UCB0599----1件: 6 💬
18UCB3491----1件: 145 💬
19UCB4940----3件: 46, 97, 271 💬
20UCB5857----1件: 53 💬
21UCB76651件: Rozanolixizumab1件: Rozanolixizumab 💬 --3件: 11, 14, 63 💬
22UCB7853----1件: 6 💬
23Ucmsc----2件: 51, 94 💬
24Ucmsc group----1件: 97 💬
25Udca1件: Ursodeoxycholic acid1件: Ursodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬5件: 67, 93, 94, 97, 296 💬
26Udenafil1件: Udenafil1件: Udenafil 💬 1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬2件: 86, 210 💬
27UF-021----1件: 90 💬
28UK 092480----1件: 86 💬
29UK-427,857----1件: 46 💬
30UK-92,480----1件: 86 💬
31UK-92,480-10----1件: 86 💬
32UK: sativex oromucosal spray2件: Cannabidiol,
Dronabinol		2件: Dronabinol ,
Cannabidiol 💬 		2件: CNR1,
CNR2 💬 		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 13 💬
33Ularitide1件: Ularitide---1件: 86 💬
34Ulcerative colitis diet----1件: 97 💬
35Ulcerative colitis exclusion diet----1件: 97 💬
36Ulefnersen1件: Ulefnersen---1件: 2 💬
37Ulinastatin1件: Ulinastatin1件: Ulinastatin 💬 6件: CTRB,
CTRB,
ELANE,
PRSS1_2_3,
PRSS1_2_3,
PRSS1_2_3 💬 		7件: Influenza A, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pancreatic secretion, Protein digestion and absorption, Systemic lupus erythematosus, Transcriptional misregulation in cancer 💬1件: 70 💬
38Ulipristal acetate1件: Ulipristal2件: Ulipristal ,
Ulipristal acetate 💬 		1件: PGR 💬 5件: Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬1件: 10 💬
39Ultevursen1件: Ultevursen---2件: 90, 303 💬
40Ultomiris1件: Ravulizumab1件: Ravulizumab 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬7件: 2, 11, 13, 50, 62, 66, 109 💬
41Ultomiris - 300 MG - concentrato PER soluzione PER infusione - USO endovenoso - flaconcino (vetro) 3 ML (100 MG / ML) - 1 flaconcino1件: Ravulizumab1件: Ravulizumab 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 62 💬
42Ultomiris 1,100 MG/11 ML1件: Ravulizumab1件: Ravulizumab 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 11 💬
43Ultomiris 300 MG/30 ML1件: Ravulizumab1件: Ravulizumab 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 66 💬
44Ultomiris 300MG/30ML1件: Ravulizumab1件: Ravulizumab 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 62 💬
45Ultra-HIGH-caloric carbohydrate-rich diet----1件: 2 💬
46Ultra-HIGH-caloric fatty diet----1件: 2 💬
47Ultracet----1件: 271 💬
48Ultrase® MT12----1件: 299 💬
49Ultrase® MT20----1件: 299 💬
50Ultrasmall particles OF iron oxide----1件: 13 💬
51Ultrasonographic assessment OF cervical multifidus and longus colli muscle thickness, postural balance and limit OF stability using THE balance platform,cervical flexion and extension strength----1件: 271 💬
52Ultrasonography assessment----1件: 49 💬
53Ultrasound----2件: 46, 171 💬
54Ultrasound elastography----1件: 96 💬
55Ultrasound imaging----2件: 34, 96 💬
56Ultrasound microbubble contrast agent----1件: 96 💬
57Ultrasound SUB-study OF assessment OF appendage muscles using ultrasound----1件: 299 💬
58Ultrasound vascularity----1件: 96 💬
59Ultrasound-guided suprascapular nerve block----1件: 149 💬
60Ultresa----1件: 299 💬
61Ultromiris----1件: 13 💬
62Ulviprubart1件: Ulviprubart1件: Ulviprubart 💬 --1件: 15 💬
63Umbilical cord blood----1件: 60 💬
64Umbilical cord blood after myeloablative conditioning----1件: 60 💬
65Umbilical cord blood after reduced-intensity conditioning----1件: 60 💬
66Umbilical cord blood CD19-bcma CAR-T cells infusion----2件: 51, 53 💬
67Umbilical cord blood mononuclear cells----1件: 97 💬
68Umbilical cord blood therapy----2件: 2, 6 💬
69Umbilical cord blood transplantation----5件: 60, 65, 284, 285, 326 💬
70Umbilical cord blood unit----1件: 333 💬
71Umbilical cord derived mesenchymal stem cell (UC -MSC) transplantation----2件: 93, 296 💬
72Umbilical cord derived mesenchymal stem cells----1件: 13 💬
73Umbilical cord lining stem cells----1件: 50 💬
74Umbilical cord mesenchymal stem cell----1件: 113 💬
75Umbilical cord mesenchymal stem cells----5件: 13, 46, 57, 97, 113 💬
76UN-alpha-R 0.25µG----1件: 235 💬
77Unavailable----1件: 36 💬
78Uncoupled rbcs----1件: 13 💬
79Undetermined----2件: 96, 97 💬
80Undifferentiated autologous mesenchymal stem cells----1件: 13 💬
81Unified parkinson'S disease rating scale----1件: 6 💬
82Uniplas----1件: 64 💬
83Universal allogeneic ANTI-CD19/bcma CAR T-cells----1件: 61 💬
84Universal bcma CAR-T----2件: 11, 13 💬
85Universal BCMA-CD19 cart----1件: 13 💬
86Universal CD19 CAR-T----2件: 11, 13 💬
87UNK----1件: 77 💬
88Unknown----3件: 34, 67, 97 💬
89Unoprostone1件: Unoprostone2件: Isopropyl unoprostone ,
Unoprostone 💬 		1件: PTGFR 💬 3件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway 💬1件: 90 💬
90Unrelated donor bone marrow transplant----1件: 60 💬
91Unrelated umbilical cord blood transplant----1件: 19 💬
92Unstimulated saliva sampling----1件: 98 💬
93Unsupervised exercise----1件: 299 💬
94Untreated cohort----1件: 85 💬
95Untreated contemporaneous cohort----1件: 118 💬
96Untreated TO atorvastatin treatment----1件: 13 💬
97Upadacitinib1件: Upadacitinib3件: Upadacitinib ,
Upadacitinib tartrate ,
Upadacitinib hydrate 💬 		1件: JAK1 💬 27件: Coronavirus disease - COVID-19, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬10件: 40, 41, 46, 49, 53, 55, 96, 97, 107, 271 💬
98Upadacitinib - direct compression-yellow1件: Upadacitinib3件: Upadacitinib ,
Upadacitinib tartrate ,
Upadacitinib hydrate 💬 		1件: JAK1 💬 27件: Coronavirus disease - COVID-19, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 97 💬
99Upadacitinib - WET granulation-yellow1件: Upadacitinib3件: Upadacitinib ,
Upadacitinib tartrate ,
Upadacitinib hydrate 💬 		1件: JAK1 💬 27件: Coronavirus disease - COVID-19, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 97 💬
100Upadacitinib -direct compression-yellow1件: Upadacitinib3件: Upadacitinib ,
Upadacitinib tartrate ,
Upadacitinib hydrate 💬 		1件: JAK1 💬 27件: Coronavirus disease - COVID-19, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 97 💬
101Upadacitinib 12MG1件: Upadacitinib3件: Upadacitinib ,
Upadacitinib tartrate ,
Upadacitinib hydrate 💬 		1件: JAK1 💬 27件: Coronavirus disease - COVID-19, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
102Upadacitinib 15 MG1件: Upadacitinib3件: Upadacitinib ,
Upadacitinib tartrate ,
Upadacitinib hydrate 💬 		1件: JAK1 💬 27件: Coronavirus disease - COVID-19, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
103Upadacitinib 15MG1件: Upadacitinib3件: Upadacitinib ,
Upadacitinib tartrate ,
Upadacitinib hydrate 💬 		1件: JAK1 💬 27件: Coronavirus disease - COVID-19, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
104Upadacitinib 30MG1件: Upadacitinib3件: Upadacitinib ,
Upadacitinib tartrate ,
Upadacitinib hydrate 💬 		1件: JAK1 💬 27件: Coronavirus disease - COVID-19, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
105Upadacitinib 3MG1件: Upadacitinib3件: Upadacitinib ,
Upadacitinib tartrate ,
Upadacitinib hydrate 💬 		1件: JAK1 💬 27件: Coronavirus disease - COVID-19, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
106Upadacitinib extended release oral tablet1件: Upadacitinib3件: Upadacitinib ,
Upadacitinib tartrate ,
Upadacitinib hydrate 💬 		1件: JAK1 💬 27件: Coronavirus disease - COVID-19, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 97 💬
107Upadacitinib oral product1件: Upadacitinib3件: Upadacitinib ,
Upadacitinib tartrate ,
Upadacitinib hydrate 💬 		1件: JAK1 💬 27件: Coronavirus disease - COVID-19, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 97 💬
108Upadaticitib----1件: 96 💬
109Uplizna1件: Inebilizumab1件: Inebilizumab 💬 1件: CD19 💬 5件: B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬3件: 11, 13, 300 💬
110Uplyso----1件: 19 💬
111Upper limb exercise----1件: 6 💬
112Upper limb muscle block----1件: 149 💬
113Upper member arterial doppler echography with analysis OF FMD----1件: 58 💬
114Uptravi1件: Selexipag1件: Selexipag 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬3件: 84, 86, 88 💬
115Uptravi® film coated tablets1件: Selexipag1件: Selexipag 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
116UR-12746-S----1件: 97 💬
117Urate1件: Uric acid---1件: 6 💬
118Urbason----1件: 97 💬
119Urbason 40 MG----1件: 13 💬
120Urbason 40 MG comprimidos----1件: 13 💬
121Urbason forte----1件: 13 💬
122Urbason solubile forte 1000MG----1件: 13 💬
123Urbason*IM EV 1F 250MG+1F 5ML----1件: 222 💬
124Urbason® solubile forte 1000 MG----1件: 13 💬
125Urea1件: Urea2件: Urea ,
Urea C13 💬 		--1件: 72 💬
126Urea cycle flux study1件: Urea2件: Urea ,
Urea C13 💬 		--1件: 251 💬
127URG101----1件: 226 💬
128Uridine1件: Uridine---1件: 299 💬
129Urinalysis----1件: 49 💬
130Urinary collect----1件: 299 💬
131Urinary levels OF piiinp AS A marker OF changes IN renal function----1件: 299 💬
132Urine collection----3件: 19, 215, 216 💬
133Urine sample----4件: 49, 51, 61, 84 💬
134Urine samples----1件: 13 💬
135Urine samples collect----1件: 234 💬
136Urine samples taken TO measure methotrexate and ITS major metabolite 7-OH-methotrexate level----1件: 46 💬
137Urine sampling----1件: 98 💬
138Urodilatin----1件: 86 💬
139Urodynamic study----1件: 226 💬
140Uromitexan----1件: 85 💬
141Ursochol 300----1件: 67 💬
142Ursodeoxycholic acid1件: Ursodeoxycholic acid1件: Ursodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬8件: 6, 67, 84, 93, 94, 95, 96, 97 💬
143Ursodeoxycholic acid (udca) 500 MG1件: Ursodeoxycholic acid1件: Ursodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 46 💬
144Ursodeoxycholic acid 300MG capsule1件: Ursodeoxycholic acid1件: Ursodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
145Ursodeoxycholic acid 300MG tablet1件: Ursodeoxycholic acid1件: Ursodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
146Ursodeoxycholic acid capsules1件: Ursodeoxycholic acid1件: Ursodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
147Ursodeoxycholic acid combination OF immunosuppressive agents1件: Ursodeoxycholic acid1件: Ursodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬2件: 93, 95 💬
148Ursodeoxycholic acid combined with total glucosides OF paeony1件: Ursodeoxycholic acid1件: Ursodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
149Ursodeoxycholic acid only1件: Ursodeoxycholic acid1件: Ursodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
150UrsodeoxycholsäURE----1件: 93 💬
151Ursodiol1件: Ursodeoxycholic acid1件: Ursodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬6件: 8, 20, 93, 97, 234, 299 💬
152Ursodoxicoltaurina----1件: 2 💬
153Ursodoxicoltaurine1件: Tauroursodeoxycholic acid1件: Taurursodiol 💬 --1件: 2 💬
154Ursodoxycoltaurine----1件: 2 💬
155Ursofalk1件: Ursodeoxycholic acid1件: Ursodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬4件: 93, 94, 96, 97 💬
156Ursofalk® 500 MG FILM-coated tablets1件: Ursodeoxycholic acid1件: Ursodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
157Ursofalk® 500 MG filmtabletten1件: Ursodeoxycholic acid1件: Ursodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
158Ursofalk® capsules1件: Ursodeoxycholic acid1件: Ursodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
159Ursolic acid1件: Ursolic acid---1件: 94 💬
160Ursonorm----1件: 6 💬
161US guided espb----1件: 70 💬
162US TAP bupivacaine/epinephrine----2件: 96, 97 💬
163US-ocrevus----1件: 13 💬
164Usan: sebelipasa alfa1件: Sebelipase alfa1件: Sebelipase alfa 💬 1件: LIPA 💬 4件: Cholesterol metabolism, Efferocytosis, Lysosome, Steroid biosynthesis 💬1件: 19 💬
165Usan: sebelipase alpha----1件: 19 💬
166USE OF A postpartum diary and additional blood draws----1件: 288 💬
167USE OF bioanalytical assay TO monitor plasma levels OF perhexiline1件: Perhexiline2件: Perhexiline maleate ,
Perhexiline 💬 		8件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S,
CPT1A,
CPT1B,
CPT1C,
CPT2 💬 		47件: AMPK signaling pathway, Adipocytokine signaling pathway, Adrenergic signaling in cardiomyocytes, Alcoholic liver disease, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Dopaminergic synapse, Efferocytosis, Fatty acid degradation, GABAergic synapse, Glucagon signaling pathway, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin resistance, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, PPAR signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Thermogenesis, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 58 💬
168Ushstat----2件: 90, 303 💬
169Uspio MRI - gadolinium MRI----1件: 13 💬
170Ustekinumab1件: Ustekinumab1件: Ustekinumab 💬 3件: IL12A,
IL12B,
IL23A 💬 		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬16件: 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
171Ustekinumab - standard dosage1件: Ustekinumab1件: Ustekinumab 💬 3件: IL12A,
IL12B,
IL23A 💬 		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬2件: 96, 97 💬
172Ustekinumab 130 MG IV1件: Ustekinumab1件: Ustekinumab 💬 3件: IL12A,
IL12B,
IL23A 💬 		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬2件: 96, 97 💬
173Ustekinumab 180 MG1件: Ustekinumab1件: Ustekinumab 💬 3件: IL12A,
IL12B,
IL23A 💬 		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 93 💬
174Ustekinumab 4.5 MG/KG1件: Ustekinumab1件: Ustekinumab 💬 3件: IL12A,
IL12B,
IL23A 💬 		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 96 💬
175Ustekinumab 45 MG1件: Ustekinumab1件: Ustekinumab 💬 3件: IL12A,
IL12B,
IL23A 💬 		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 93 💬
176Ustekinumab 6 MG/KG1件: Ustekinumab1件: Ustekinumab 💬 3件: IL12A,
IL12B,
IL23A 💬 		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 50 💬
177Ustekinumab 90 MG1件: Ustekinumab1件: Ustekinumab 💬 3件: IL12A,
IL12B,
IL23A 💬 		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬5件: 49, 50, 93, 96, 97 💬
178Ustekinumab 90 MG (SC) group 11件: Ustekinumab1件: Ustekinumab 💬 3件: IL12A,
IL12B,
IL23A 💬 		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 96 💬
179Ustekinumab 90 MG (SC) group 21件: Ustekinumab1件: Ustekinumab 💬 3件: IL12A,
IL12B,
IL23A 💬 		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 96 💬
180Ustekinumab 90 MG SC Q12W1件: Ustekinumab1件: Ustekinumab 💬 3件: IL12A,
IL12B,
IL23A 💬 		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬2件: 96, 97 💬
181Ustekinumab 90 MG SC Q8W1件: Ustekinumab1件: Ustekinumab 💬 3件: IL12A,
IL12B,
IL23A 💬 		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬2件: 96, 97 💬
182Ustekinumab and semi enteral nutrition1件: Ustekinumab1件: Ustekinumab 💬 3件: IL12A,
IL12B,
IL23A 💬 		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 96 💬
183Ustekinumab and upadacitinib1件: Ustekinumab1件: Ustekinumab 💬 3件: IL12A,
IL12B,
IL23A 💬 		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 96 💬
184Ustekinumab dose based ON BSA and body weight1件: Ustekinumab1件: Ustekinumab 💬 3件: IL12A,
IL12B,
IL23A 💬 		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 97 💬
185Ustekinumab injection1件: Ustekinumab1件: Ustekinumab 💬 3件: IL12A,
IL12B,
IL23A 💬 		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 160 💬
186Ustekinumab IV1件: Ustekinumab1件: Ustekinumab 💬 3件: IL12A,
IL12B,
IL23A 💬 		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬2件: 49, 97 💬
187Ustekinumab IV infusion1件: Ustekinumab1件: Ustekinumab 💬 3件: IL12A,
IL12B,
IL23A 💬 		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬2件: 96, 97 💬
188Ustekinumab liquid IN prefilled syringe1件: Ustekinumab1件: Ustekinumab 💬 3件: IL12A,
IL12B,
IL23A 💬 		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 84 💬
189Ustekinumab SC1件: Ustekinumab1件: Ustekinumab 💬 3件: IL12A,
IL12B,
IL23A 💬 		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬2件: 49, 97 💬
190Ustekinumab SC injection1件: Ustekinumab1件: Ustekinumab 💬 3件: IL12A,
IL12B,
IL23A 💬 		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬2件: 96, 97 💬
191Usual care ARM exercise----1件: 6 💬
192Usual current care----2件: 96, 97 💬
193Usual diet with dietary guidelines FOR americans diet information----1件: 13 💬
194Usual DMT continuation----1件: 13 💬
195Usual dopaminergic PER OS treatment----1件: 6 💬
196Usual drug treatment OF parkinson'S disease----1件: 6 💬
197Usual urogynecologic care----1件: 226 💬
198UT-15 SR----1件: 51 💬
199UT-15C----1件: 86 💬
200UT-15C 0.25 MG----1件: 86 💬
201UT-15C 1 MG----1件: 86 💬
202UT-15C 5 MG----1件: 86 💬
203UT-15C LP----1件: 86 💬
204UT-15C SR----2件: 51, 86 💬
205UT-15C-SR----2件: 51, 86 💬
206UTAA91 injection----3件: 46, 49, 51 💬
207Utreloxastat1件: Utreloxastat1件: Utreloxastat 💬 1件: ALOX15 💬 6件: Arachidonic acid metabolism, Efferocytosis, Ferroptosis, Linoleic acid metabolism, Necroptosis, Serotonergic synapse 💬1件: 2 💬
208UTTR1147A----2件: 96, 97 💬
209UTTR1147A, IL22-FC, IL-22FC1件: Efmarodocokin alfa1件: Efmarodocokin alfa 💬 1件: IL22 💬 4件: Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Th17 cell differentiation 💬2件: 96, 97 💬
210Uvadex1件: Methoxsalen1件: Methoxsalen 💬 --3件: 46, 51, 96 💬
211Uvadex and uvar XTS photopheresis system----1件: 96 💬
212UVB----1件: 298 💬
213Uvedose----2件: 13, 46 💬
214Uvedose 100 000 UI, solution buvable EN ampoule----1件: 13 💬
215UX-DA001----1件: 6 💬
216UX001----1件: 30 💬
217UX003----1件: 19 💬
218UX007----5件: 8, 248, 256, 257, 344 💬
219UX0531件: UX053---1件: 257 💬
220UX1111件: Rebisufligene etisparvovec---1件: 19 💬
221UX143, BPS804----1件: 274 💬
222UX7011件: UX701---1件: 171 💬